rebel Financial rebel Financial
← All Posts
MDT

Medtronic plc

October 16, 2026 • Author: Phil Ratcliff • MDT
Item Proposal Vote
1 Electing, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2027 Annual General Meeting of Medtronic plc (the "Company").
1a Craig Arnold ✓ For
1b Scott C. Donnelly ✓ For
1c Lidia L. Fonseca ✓ For
1d John P. Groetelaars ✓ For
1e Randall J. Hogan, III ✓ For
1f William R. Jellison ✓ For
1g Joon S. Lee, M.D. ✓ For
1h Gregory P. Lewis ✓ For
1i Kevin E. Lofton ✓ For
1j Geoffrey S. Martha ✗ Against
1k Elizabeth G. Nabel, M.D. ✓ For
1l Kendall J. Powell ✓ For
2 Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2027 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. ✓ For
3 Approving, on an advisory basis, the Company's executive compensation. ✓ For
4 Renewing the Board of Directors' authority to issue shares under Irish law. ✓ For
5 Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law. ✓ For
6 Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. ✓ For
Attachments
📄
MDT_Annual_Report_10122026.pdf 1.7 MB
📄
MDT_Proxy_Statement_10122026.pdf 28.7 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.